Can hematopoietic stem cell transplant be used to treat allergic asthma

Updated on healthy 2024-06-29
17 answers
  1. Anonymous users2024-02-12

    Dietary therapy for asthma is very important, it can reduce the use of drugs and *** rarely, such as eating certain foods can reduce the amount of drugs, and also include avoiding foods such as avoiding seafood can reduce the number of asthma attacks at night. In the Asthma Prevention and Treatment Q&A in the "China Allergy and Asthma Network", you can see an article about "Dietary Therapy for Asthma", which is very good, novel and rich, you can take a look.

    However, dietary therapy is only an adjunct. Because asthma is allergic, it usually has sudden onset of dyspane, which is more severe at night, and it is very difficult to breathe, and it is very uncomfortable to hold on. In this case, you should inhale albuterol aerosol immediately, which can be relieved quickly, but should not be used for a long time.

    Many people also have symptoms of allergic rhinitis such as nasal congestion, nasal itching, sneezing in the morning, and runny nose, which is medically known as "allergic rhinitis asthma syndrome".

    In fact, you should go to your local allergy center to find out what food you are allergic to, asthma needs dietary therapy, and you need to avoid it. Nowadays, most doctors are willing to use hormones, in fact, try not to use hormones to **asthma, which can form dependence and a lot of ***. The ** of asthma diet therapy is in the asthma column in the China Allergy and Asthma Network.

  2. Anonymous users2024-02-11

    Compendium of Materia Medica" records that crocodile meat has a good therapeutic effect on asthma and bronchitis, Teresa Teng also went to Thailand to eat crocodile meat for asthma, it is recommended that you can learn about relevant information, one more way to have more hope, I wish you good health and a happy life! --Taiyudo.

  3. Anonymous users2024-02-10

    I also have allergic asthma, I have been taking a lot of medicines, there is no good way, this disease is life-threatening all the time, it is best to buy a kind of medicine around you, called Sulidie, vice. The effect is small, long-term sucking, one sucking 60 times, more than 200 yuan a.

  4. Anonymous users2024-02-09

    1.At present, hematopoietic stem cell transplantation ** rheumatism is still in the experimental research stage, and several successful cases have been reported abroad.

    2.This is a first-class method, but the current technology and method are not mature enough, and the observation of long-term efficacy is not enough.

    Effective, but ** words are hard to say.

  5. Anonymous users2024-02-08

    Effective, but ** words are hard to say.

  6. Anonymous users2024-02-07

    The Ministry of Health has formulated and issued the Administrative Measures for the Clinical Application of Medical Technology, which implements classified and hierarchical management of medical technology, of which stem cell transplantation technology belongs to the third category of medical technology. At present, except for hematopoietic stem cell transplantation technology** blood system diseases, other stem cell transplantation is not allowed to be used in clinical practice for the time being.

  7. Anonymous users2024-02-06

    Hematopoietic stem cell transplantation can be used for ** tumor diseases such as leukemia, certain malignant solid tumors and non-tumor diseases such as aplastic anemia, severe immunodeficiency disease, acute radiation sickness, thalassemia, etc.

    Transplant care. Management of the patient prior to admission to the laminar flow ward.

    Disinfection of indoor items: Clothes, quilts, medicines, utensils, toilets, books and newspapers need to be disinfected to prevent external infection.

    Comprehensive examination: special attention should be paid to check whether there is an infection foci, and if infection or carrier is found, it should be actively **, and the chronic and potential infection foci should be completely removed.

    Nail trimming and haircutting before entering the room. Clean the enema on the day of entry. After bathing, take a medicated bath with 1 2 000 chlorhexidine solution for 30 min, change sterile clothes, shoes, hats, and wear sterile masks, and then enter the 100-level air laminar flow room, and do not walk out of the ultra-clean area without authorization after entering the room.

    Intravenous catheterization: Subclavian vein catheterization was performed 1 day before transplantation, and it was used as a backup.

    Whole environmental protection.

    Admitted to the Class 100 sterile laminar flow ward (LAFR), LAFR walls, countertops, doors, windows, and floors are wiped with disinfectant and cleaning agent, 1 time a day, and the indoor air is disinfected with peracetic acid spray once a week.

    Eat a sterile diet: Cooked meals, beverages are sterilized in the microwave oven at high heat before consumption, and tableware is sterilized at the same time each time. The fruit was soaked and sterilized in 1 2 000 chlorhexidine solution for 30 min and then peeled and eaten.

    Oral tablets were irradiated with positive and negative ultraviolet rays for 30 minutes before being taken by patients.

    Intestinal disinfection: daily oral administration does not absorb antibiotics such as berberine.

    Disinfection: Clean surfaces 1 time per day. Chloramphenicol 1% and rifampicin eye drops alternately 2 times a day. A 75% ethanol cotton swab rubs the external auditory canal 3 times a day. Wash after using the toilet or take a sitz bath, and spray hands with 75% alcohol.

  8. Anonymous users2024-02-05

    Hematopoietic stem cell transplantation**Indications:1Malignant tumors, malignant tumors represented by leukemia.

    2.Non-malignant tumors, including lymphoma, myeloma, aplastic anemia, etc. 3.

    Autoimmune diseases, combined immunodeficiency or severe immunodeficiency diseases, such as systemic lupus erythematosus, etc.

  9. Anonymous users2024-02-04

    The principle of hematopoietic stem cell transplantation**Leukemia is: first, with the help of high-dose radiotherapy and chemotherapy, the malignant cells in the patient's body are eliminated to the greatest extent, and then the normal hematopoietic stem cells are transfused, and the transplanted stem cells "settle" in the new environment, differentiate and multiply, help the disease "rebuild home", and get through the difficult period when the blood and immune system lose normal function after being severely damaged.

    The use of large doses of radiation and chemical drugs can also kill tumor cells in the blood, effectively curbing the development of leukemia. However, this kind of killing is "friend or foe", killing tumor cells and killing normal cells at the same time, endangering the patient's life. Therefore, neither radiotherapy nor chemotherapy is as effective as bone marrow transplantation, or hematopoietic stem cell transplantation** leukemia.

    Hematopoietic stem cell transplantation is the greatest clinical achievement of the 20th century.

    What diseases can hematopoietic stem cell transplantation have? Diseases that have been transplanted with hematopoietic stem cells** include: hematologic malignancies such as leukemia, multiple myeloma, myelodysplastic syndrome, lymphoma, etc.; Certain malignant solid tumors, such as neuroblastoma, small cell lung cancer, germ cell carcinoma, etc.; and non-neoplastic diseases, such as bone marrow hematopoietic dysfunction, severe immunodeficiency disease, inborn metabolic defect disease, hemoglobinopathy, etc

    Acute radiation sickness, etc.

    At present, there are some new breakthroughs in the research of hematopoietic stem cells, such as those for severe pemphigus (aseptic necrosis of the bilateral femoral head) and myasthenia gravis. With the rapid development of hematopoietic stem cell transplantation technology, the number of diseases is still increasing.

    Hematopoietic stem cell transplantation is divided into four types: bone marrow hematopoietic stem cell transplantation, peripheral blood hematopoiesis, cell transplantation, umbilical cord blood hematopoietic stem cell transplantation and fetal liver hematopoietic stem cell transplantation.

  10. Anonymous users2024-02-03

    Hematopoietic stem cells can be used in the following diseases: acute lymphoblastic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, chronic myeloid leukemia, blast-crisis non-Hodgkin lymphoma, low-grade malignant Hodgkin lymphoma, CR1; Refractory myelodysplastic syndromes, multiple myeloma and other plasmacytomas, myeloproliferative disorders such as essential erythrocytosis, thrombocythemia, and primary myelofibrosis solid tumors: breast cancer, germ cell tumors, ovarian cancer, glioma, small cell lung cancer, non-small cell lung cancer, autoimmune diseases:

    Thrombocytopenic purpura, systemic sclerosis, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, amyloidosis.

  11. Anonymous users2024-02-02

    Hematopoietic stem cell transplantation refers to the injection of normal donor or autologous hematopoietic stem cells into the patient's body after total body irradiation, chemotherapy and immunosuppressive pretreatment to rebuild normal hematopoietic and immune function. Hematopoietic stem cells have the function of proliferation and differentiation into mature blood cells of various lines and the ability to self-differentiate, and maintain lifelong continuous hematopoiesis. Hematopoietic stem cells express CD34 antigen, and after 50 years of continuous development, hematopoietic stem cells have become clinically important and effective.

    The number of transplant cases is increasing every year around the world, and the longest lifespan of transplant patients is more than 30 years.

  12. Anonymous users2024-02-01

    Yes, the risk is relatively high, and it is not recommended for non-heavy cases.

  13. Anonymous users2024-01-31

    Hello, according to your question, sort out the following answers, in general, stem cells**, that is, hematopoietic stem cell transplantation**, hematopoietic stem cell transplant** can** many hematologic diseases, especially most hematologic malignant diseases. With hematopoietic stem cell transplantation, it is possible to have malignant disease. In patients with acute leukemia, in addition to acute promyelocytic leukemia, other types of acute leukemia can only be completely treated with hematopoietic stem cell transplantation, and other chemotherapy methods cannot be thorough, and the rate of patients is higher.

    For patients with lymphoma, or patients with multiple myeloma, autologous hematopoietic stem cell transplantation can be used to significantly prolong the survival of patients and even achieve the goal. In addition, some autoimmune diseases, such as systemic lupus erythematosus, have also been achieved through stem cell transplantation. Stem cell transplantation can lead to a variety of hematologic diseases, while other non-hematologic diseases may also be treated with stem cells.

    Questions. Can stem cells cure tuberculosis?

    Hello, stem cells have little effect on tuberculosis.

    Questions. And can his methods cure the roots?

    Tuberculosis requires you to fight tuberculosis** and take your medication regularly.

    Questions. Oh thanks.

    You're welcome. Dear, if I can help you, please give a thumbs up, your satisfaction is my motivation! I wish you a happy family and all the best.

  14. Anonymous users2024-01-30

    What diseases can autologous transplantation do So far, radiotherapy and chemotherapy are still the main means of burying advanced malignant tumors. Although chemotherapy and radiotherapy can kill a large number of tumor cells in patients, a considerable number of malignant tumors are insensitive to chemoradiotherapy or are easily susceptible, and the efficacy of chemoradiotherapy is greatly limited by dose.

    Since the successful development of hematopoietic stem cell transplantation in the 60s of the last century, hematopoietic stem cell transplantation in China has also developed rapidly and achieved good results. According to hematopoietic stem cells**, hematopoietic stem cell transplantation is mainly divided into two categories: autologous hematopoietic interference rotten cell transplantation and allogeneic hematopoietic stem cell transplantation (including syngeneic transplantation).

    Autologous hematopoietic stem cell transplantation can accelerate hematopoietic recovery and immune reconstitution, thereby increasing the body's tolerance dose to chemoradiotherapy and significantly improving the efficacy. Moreover, autologous transplantation is relatively simple and easy to perform, transplantation-related complications and risks are small, the patient cost is less, the success rate of transplantation is high, and the curative effect is better.

    Autologous hematopoietic stem cell transplantation can lead to malignant lymphoma, breast cancer, neuroblastoma in children, reproductive tumors, small cell lung cancer, kidney cancer, malignant melanoma, etc. Autologous hematopoietic stem cell slow-leakage transplantation is mainly for patients with advanced malignant tumors who are sensitive to chemoradiotherapy, or cases with ineffective, high-grade or malignant conventional treatment.

  15. Anonymous users2024-01-29

    Mainly acquired blood diseases and immune system diseases, such as leukemia, aplastic anemia, multiple myeloma and malignant lymphoma, etc.

  16. Anonymous users2024-01-28

    This one is too professional to understand.

  17. Anonymous users2024-01-27

    Hematopoietic stem cell transplantation mainly includes bone marrow transplantation, peripheral blood stem cell transplantation, and umbilical cord blood stem cell transplantation. Since bone marrow is a hematopoietic organ, bone marrow transplantation was performed in the early days. In 1958, the French oncologist Mathe first performed a bone marrow transplant on a patient who had been injured by a radiation accident.

    In 1968, GATTI successfully applied bone marrow transplantation to a severe combined immunodeficiency patient. After the 70s of the last century, with the discovery of human leukocyte antigen (HLA), the progress of blood products and antibiotics, the protection of the environment and the wide application of hematopoietic growth factors, hematopoietic stem cell transplantation technology has developed rapidly. In 1977, Thomas reported that 13 of 100 patients with advanced leukemia had miraculously survived long-term bone marrow transplantation with HLA-concomitant positive nucleus.

    Since then, the world has achieved great success in the application of bone marrow transplantation for leukemia, aplastic anemia and other serious blood diseases, acute radiation sickness and some malignant tumors, creating a new era of clinical leukemia and malignant tumors.

Related questions
9 answers2024-06-29

It is a pre-transplant treatment. This is a measure taken to enable the recipient to accept foreign hematopoietic stem cells and to reduce the burden on their own tumor cells, and the classic regimen is cyclophosphamide 60 mg kg body weight taken for 3 days plus 8 12 gray of one or divided total body irradiation. This scheme is more damaging to the patient, and is mostly used for patients who are in good health, younger in age, have a shorter course of disease, and have good function of major organs. >>>More

4 answers2024-06-29

Keep the indoor air fresh, open the windows for 30 minutes every morning and evening to ventilate and reduce family gatherings. Remember to wear a mask when you go out within six months after transplantation or when your blood white blood cell count is lower than normal. In order to avoid the multiplication of bacteria, patients who love pets must be circumcised from the perspective of their own health. >>>More

8 answers2024-06-29

1. It is necessary to find a suitable match, because the probability of HLA (human leukocyte antigen) matching is very low, even if it is a sibling, it is only 1 4, so although the establishment of a bone marrow bank is usually used in the world to find a matching donor in the non-blood relationship, the probability of compatibility is 1 in 1,000 to 1 in 10,000. In fact, the vast majority of patients cannot find a suitable ligand, and the disease is delayed because of this. >>>More

15 answers2024-06-29

It is better not to do it, because it has a negative effect, and now the Ministry of Health has issued a notice that it is not allowed to be applied to clinical practice. I think the best thing to do is to let him walk more and not be afraid of falling, I also have cerebral palsy, I used to fall a lot, bleeding is a common thing for me. It's better to let him go to school, because you can't take him out every day, besides, he also needs to be educated, education is as important to him as important as **, because you can't train him to live a life, the road in the future still needs him to go down by himself, his age is relatively old, and if he doesn't go to school, he won't have the opportunity to go to school, and ** won't have much effect, school is the second turning point in life and the future for children with disabilities, I hope you don't learn from my parents,

8 answers2024-06-29

Hello! Let me give you a rough rundown of your question.

First of all, stem cells for ** brain atrophy has been proven to be effective, 80% of patients on the clinical surface have obvious improvement after a course of treatment, 15% of patients have symptom relief 6-12 months after the second course of treatment, and some patients have not improved significantly, I can give you an answer to the principle involved in this middle: >>>More